Orenstein warns measles comeback
- Walter Orenstein told Korea Biomedical Review that measles is returning because countries still miss people in vaccination programs, especially adults and under-vaccinated pockets. - He said national coverage can hide “pockets of susceptibles,” as South Korea counted 78 measles cases in 2025 despite retaining elimination certification. - U.S. measles cases hit 1,792 by April 23 after 2,288 in 2025, underscoring the wider rebound. (cdc.gov)
Measles is back in headlines because Walter Orenstein says the problem is not the vaccine itself, but whether health systems get shots into arms. (koreabiomed.com) In an interview published April 27, Orenstein told Korea Biomedical Review that governments often add vaccines and recommendations without making sure people actually receive them. He summed it up with a line he has used for years: “Vaccines don’t save lives -- vaccinations save lives.” (koreabiomed.com) Orenstein is a former director of the U.S. National Immunization Program at the Centers for Disease Control and Prevention and a 2026 recipient of the IVI–SK bioscience Park MahnHoon Award. He spoke in Seoul after returning to many of the same measles issues he discussed in Korea about 20 years ago. (koreabiomed.com) His warning starts with how measles spreads. The virus is so contagious that a country can post strong national coverage and still see outbreaks if one neighborhood, age group or clinic network has too many unprotected people. (koreabiomed.com) (cdc.gov) That is why Orenstein focused on “pockets of susceptibles” rather than national averages. He said officials need to ask whether missed vaccination comes from cost, distance, missed clinic visits or hesitancy, because each gap needs a different fix. (koreabiomed.com) He also pointed to adults, an area that often gets less attention than childhood schedules. Weak adult vaccination leaves room for imported cases to spread after travel and trade reconnect under-vaccinated communities across borders. (koreabiomed.com) South Korea is the example he used most directly. The country still holds World Health Organization certification for measles and rubella elimination, but Korea Biomedical Review reported 78 measles cases in 2025, citing a Korea Disease Control and Prevention Agency update. (koreabiomed.com) The warning lands as measles is already surging well beyond Korea. The U.S. Centers for Disease Control and Prevention reported 1,792 confirmed measles cases in 2026 as of April 23, with 93% linked to outbreaks, after 2,288 confirmed cases and 48 outbreaks in 2025. (cdc.gov) Europe and Central Asia also showed how quickly the virus can rebound when coverage slips. The region recorded 127,412 measles cases in 2024, the highest total in more than 25 years, before dropping to 33,998 cases in 2025 as outbreak response improved. (unicef.ch) (unicef.org) Routine coverage is still below the level needed to reliably stop spread. WHO-UNICEF estimates cited by measles partners put first-dose measles coverage at 84% globally and second-dose coverage at 76% in 2024, short of the 95% target usually cited for community protection. (measlesrubellapartnership.org) Research groups are now modeling what happens if those gaps persist. A Stanford Medicine-led study published in the Journal of the American Medical Association on April 24, 2025 found measles could become endemic in the United States again within two decades at current immunization rates. (med.stanford.edu) Orenstein’s argument is narrower and more practical than a debate over vaccine science. He said countries need stronger delivery systems, better follow-up, and more public trust, because measles returns fastest where programs look complete on paper but break down in real life. (koreabiomed.com)
